Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: J Pediatr. 2013 Feb 15;163(2):369–375.e1. doi: 10.1016/j.jpeds.2013.01.005

Table II.

General characteristics of the healthy control group and the CF groups with a normal nutritional status and with nutritional failure

Healthy controls (n=17) CF no nutritional failure (n=9) CF nutritional failure (n=7)
Sex (M/F) 8/9 5/4 5/2
Age (yrs) 22.2 ± 5.6 15.5 ± 5.9*** 15.2 ± 6.2***
Genotypes (#) DF508/DF508 (11), G551D/DF508 (2), DF508/G1244E (1), DF508/1717-1G TO, A (1), DF508/3272-26A>G (1).
Tanner stage (n: 1, 2–4, 5) 1/5/3 0/6/1
Weight (kg) 69.4 ± 17.4 54.6 ± 20.6 42.2 ± 17.2
BMI (percentile) 54.8 ± 20.7 7.9 ± 3.2##
(kg/m2) 22.0 ± 5.5
Height (m) 1.77 ± 0.44 1.61 ± 0.61 1.62 ± 0.66
(percentile) 37.0 ± 14.0 36.3 ± 14.8
FFMI (% norm) 99.3 ± 24.8 99.0 ± 40.4 81.8 ± 33.4
FMI (% norm) 106.8 ± 26.7 104.7 ± 39.6 79.0 ± 32.2
FEV1 (% pred) 88.9 ± 33.6 74.6 ± 30.4
FVC (% pred) 104.0 ± 39.3 88.7 ± 36.2
Weight change 3 mo. before admission (kg) 0.7 ± 0.2 −1.7 ± 0.7#
Weight change admission until study day (kg) 1.9 ± 0.7 1.9 ± 0.8
Exacerbations past year (nr) 0.8 ± 0.3 3.6 ± 1.5#
Hospitalizations past year (nr) 0.4 ± 0.1 2.0 ± 0.8#

Values are means ± SEM. CF: cystic fibrosis; BMI: body mass index; FFMI: fat-free mass index; FMI: fat mass index; FEV1: forced expiratory volume in one second; FVC: forced vital capacity. Significance of difference as compared with healthy controls:

**

P < 0.01,

***

P < 0.001, and to CF with no nutritional failure:

#

P < 0.05,

##

P < 0.01,

###

P < 0.001.